Dr. Song Kim has over a decade of experience in clinical development across several therapeutic areas and regions. She joins Karis Bio Inc. as a head of clinical development from Hanmi Pharmaceuticals, where she led early-stage clinical trials targeting novel therapies. Prior to Hanmi Pharmaceuticals, she served as a regional medical expert at Novartis AG and medical director at Novartis Korea leading medical programs. She also worked at McKinsey & Company, supported companies to develop an innovation strategy in Pharmaceutical sector. As a clinician by training, she earned an MD from Yonsei University and trained in dermatology at Samsung Medical Center, Korea.